Terns Pharmaceuticals $127.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Revolution Medicines $300 million follow-on offering
We advised the underwriters in connection with the equity offering
Ocumension Therapeutics HK$793.8 million top-up placement of shares
We advised the placing agent in connection with the equity offering
Venus Medtech HK$1.4 billion placing of new H shares
We advised Venus Medtech (Hangzhou) on its placement of new shares
CureVac $450 million public offering
We advised CureVac on the equity offering
Seer $251.3 million stock offering
We advised the underwriters on the SEC-registered equity offering
Surgalign Holdings $37.5 million follow-on offering
We advised the underwriters on the equity offering
Personalis, Inc. $150 million stock offering
We advised the underwriters on the equity offering
Precigen $129 million common stock offering
We advised the underwriters in connection with the SEC-registered equity offering
Cryoport $287.5 million follow-on offering
We advised the underwriters on the SEC-registered offering